Atlas Trials

A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

Clinical trial NCT04089163 · WITHDRAWN

Trial details

NCT number
NCT04089163
Sponsor
Tocagen Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2019-12-01
Primary completion
2022-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.